Metraipolis › archive › dc_f2ff2236893e

A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of… — Europe PMC PMID:41018057

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41018057
DOI: 10.3389/fped.2025.1639573
License (as archived): solo-consultazione
Archived: 2026-11-09T23:54:31.898Z
SHA-256 of the archived text: c1d0131e9d40d439f32a381f57395d89e37dd85cd32f24829b30f99379696ea7
Stable URL of this page: https://metraipolis.com/documento/dc_f2ff2236893e

How to cite

A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of… — Europe PMC PMID:41018057 — Europe PMC (en), https://europepmc.org/article/MED/41018057 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2ff2236893e (Metraipolis archive dc_f2ff2236893e, sha256 c1d0131e9d40d439f32a381f57395d89e37dd85cd32f24829b30f99379696ea7)

BibTeX

@misc{dcf2ff2236893e,
  title = {A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of… — Europe PMC PMID:41018057},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41018057},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2ff2236893e; sha256 c1d0131e9d40d439f32a381f57395d89e37dd85cd32f24829b30f99379696ea7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018057. Agents can read the archived copy with the MCP tool read_document.